C
Genmab A/S GMAB
$24.65 $0.230.94% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025
Revenue 29.37% -22.33%
Total Other Revenue -- --
Total Revenue 29.37% -22.33%
Cost of Revenue 35.71% -12.79%
Gross Profit 28.97% -22.85%
SG&A Expenses 14.29% -29.41%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 7.21% -11.65%
Operating Income 91.49% -41.97%
Income Before Tax 73.36% -52.60%
Income Tax Expenses 77.55% 241.10%
Earnings from Continuing Operations 72.31% -64.51%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 72.31% -64.51%
EBIT 91.49% -41.97%
EBITDA 86.00% -40.58%
EPS Basic 1,126.88% -94.87%
Normalized Basic EPS 1,098.23% -93.83%
EPS Diluted 1,126.52% -94.84%
Normalized Diluted EPS 1,097.92% -93.79%
Average Basic Shares Outstanding -85.96% 592.33%
Average Diluted Shares Outstanding -85.95% 587.82%
Dividend Per Share -- --
Payout Ratio -- --